Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS (CANDIS-II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00673647
Recruitment Status : Unknown
Verified August 2009 by Technische Universität Dresden.
Recruitment status was:  Active, not recruiting
First Posted : May 7, 2008
Last Update Posted : August 26, 2009
Sponsor:
Collaborator:
Federal Ministry of Health
Information provided by:
Technische Universität Dresden

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to evaluate the effectiveness of the cognitive-behavioral treatment program CANDIS among n=450 patients with cannabis use disorders in a mulicenter randomized-controlled clinical trial (n=11 outpatient treatment centers).

Condition or disease Intervention/treatment Phase
Cannabis Use Disorders Behavioral: Cognitive-behavioral treatment Phase 3

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 450 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS in the German Outpatient Treatment Service System (CANDIS-II)
Study Start Date : May 2008
Estimated Primary Completion Date : October 2009
Estimated Study Completion Date : October 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: 1
Individual psychotherapy including cognitive behavioral components, motivational interviewing techniques and case management
 Behavioral: Cognitive-behavioral treatment
10 sessions of individual psychotherapy including cognitive-behavioral treatment, motivational enhancement and a psychosocial problem training.
Other Name: delayed treatment control group
No Intervention: 2
Delayed treatment control group


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. abstinence, defined as no evidence of cannabis use during the past 4 weeks as evidenced by self report and a negative urine screen; number of times a cannabis product was used in the past 4 weeks; retention rate [ Time Frame: at the end of treatment ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • motivation to change cannabis use
  • age 16 or older
  • current (12 mth) regular cannabis use (at least 2 days a week)
  • informed consent to the study procedures and assessments

Exclusion Criteria:

  • current alcohol or any illicit drug dependence syndrome according to DSM-IV other than due to cannabis
  • lifetime history of any psychotic disorder
  • current severe episode of Major depression
  • current panic-agoraphobic disorder (severe)
  • severe learning disability, brain damage or pervasive developmental disorder
  • currently acute suicidality
  • not fluent in german language
  • any other current treatment for cannabis use disorders
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00673647


Locations
Layout table for location information
Germany
Psychosoziale Beratungs- und Behandlungsstelle für Suchtgefährdete und -kranke
Bautzen, Germany, 02625
LogIn Jugend- und Suchtberatung
Berlin, Germany, 10585
Therapieladen e.V.
Berlin, Germany, 10783
Jugend- und Drogenberatung Braunschweig
Braunschweig, Germany, 38102
Jugend- und Drogenberatung Dresden
Dresden, Germany, 01219
Die Boje - Suchtberatung und Behandlung
Hamburg, Germany, 20146
Drobs Hannover
Hannover, Germany, 30159
Caritas-Fachambulanz für junge Suchtkranke
Muenchen, Germany, 80335
Suchtambulanz der LWL-Klinik Münster
Muenster, Germany, 48147
Caritas Fachambulanz für Suchtprävention und Rehabilitation Osnabrück
Osnabrueck, Germany, 49074
Release Stuttgart e.V. & Ambulante Beratungs- und Behandlungsstelle Klinikum Stuttgart
Stuttgart, Germany, 70190
Sponsors and Collaborators
Technische Universität Dresden
Federal Ministry of Health
Investigators
Layout table for investigator information
Study Director: Hans-Ulrich Wittchen, PhD Technische Universitaet Dresden
Study Director: Gerhard Buehringer, PhD Technische Universitaet Dresden
Principal Investigator: Eva Hoch, PhD Technische Universitaet Dresden
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: PhD Eva Hoch, Technische Universitaet Dresden
ClinicalTrials.gov Identifier: NCT00673647    
Other Study ID Numbers: IIA5-2507DSM407
First Posted: May 7, 2008    Key Record Dates
Last Update Posted: August 26, 2009
Last Verified: August 2009
Keywords provided by Technische Universität Dresden:
cannabis
dependence
marijuana
CBT
efficacy of CBT for cannabis use disorders
Additional relevant MeSH terms:
Layout table for MeSH terms
Marijuana Abuse
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders